Sfoglia per Autore
Characterizing an ectopic secreting carcinoid with indium-111-DTPA-D-Phe-pentetreotide.
1997 V. Briganti; M. Mannelli; G. La Cava; A. Peri; U. Meldolesi; R. Masi; A. Pupi
Regional Cerebral blood flow measured by microsphere technique in experimental animals: tecchnical notes for the use of albumin microsperes in rats
1997 BOTTONCETTI A.; A. PUPI; MELDOLESI U
World Wide Web interface for advanced SPECT reconstruction algorithms implemented on a remote massively parallel computer
1997 A.R.Formiconi; A.Passeri; R.Guelfi; M.Masoni; A.Pupi; U.Meldolesi; P.Malfetti; L.Calori; A.Guidazzoli
Prediction of post-revascularization functional recovery of asynergic myocardium using quantitative 201Tl rest-redistribution tomography: has the reverse redistribution pattern an independent significance?
1998 R. SCIAGRA'; PUPI A; PELLEGRI M; MATTEINI M; SANTORO GM; BISI G; FAZZINI PF.
EVIDENCE OF INTESTINAL INFLAMMATION BY 99mTc-HMPAO-LABELLED LEUKOCYTE SCINTIGRAPHY IN HLA-B27 POSITIVE NON IBD PEDIATRIC PATIENTS
1998 Lionetti P.; Pupi A.; Veltroni M.; Ermini M.; Ferrari R.; Resti M.; Falcini F.
Rest-redistribution thallium-201 SPECT to detect myocardial viability.
1998 R. SCIAGRA'; SANTORO GM; BISI G; PEDENOVI P; FAZZINI PF; PUPI A.
First-pass cerebral extraction of benzamide-derivative radiotracers for SPECT
1998 BOTTONCETTI A; A. PUPI; SESTINI S.; PECORALE A.; RASPANTI S.; MELDOLESI U.
Regional cerebral blood flow in juvenile systemic lupus erythematosus: a prospective SPECT study. Single photon emission computed tomography
1998 Falcini F; De Cristofaro MT; Ermini M; Guarnieri M; Massai G; Olmastroni M; Masi A; Pupi A; Meldolesi U.
Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations.
1999 Sabbadini MG; Manfredi AA; Bozzolo E; Ferrario L; Rugarli C; Scorza R; Origgi L; Vanoli M; Gambini O; Vanzulli L; Croce D; Campana A; Messa C; Fazio F; Tincani A; Anzola G; Cattaneo R; Padovani A; Gasparotti R; Gerli R; Quartesan R; Piccirilli M; Farsi A; Emmi E; Passaleva A;Pupi A; Massacesi L
Evidence of subclinical intestinal inflammation by 99m technetium leukocyte scintigraphy in patients with HLA-B27 positive juvenile onset active spondyloarthropathy
2000 P. LIONETTI; PUPI A; VELTRONI M; FONDA C; CAVICCHI MC; AZZARI C; FALCINI F
Use of technetium-99m hexamethylpropylene amine oxime single-photon emission tomography for the study of cerebral blood flow reactivity after acetazolamide infusion in patients with Behçet’s disease.
2000 PUPI A; SESTINI S; DE CRISTOFARO M.T; EMMI L; MARCHIONE T; SALVATI G; LI GOBBI F; MASSACESI L; MELDOLESI U;
Evidence of subclinical intestinal inflammation by 99m technetium leukocyte scintigraphy in patients with HLA-B27 positive juvenile onset active spondyloarthropathy
2000 Lionetti P.; Pupi A.; Veltroni M.; Fonda C.; Cavicchi M.C.; Azzari C.; Falcini F.
Prognostic implications of Tc-99m sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction.
2000 SCIAGRA' R.; PELLEGRI M.; A. PUPI; BISI G.; CARNOVALE V.; SANTORO GM.
Use of technetium-99m hexamethylpropylene amine oxime SPET for the study of cerebral blood flow reactivity after acetazolamide infusion in patients with Behcet's disease.
2000 A. PUPI; SESTINI S; EMMI L; MARCHIONE T; SALVATI G; GOBBI FL; MASSACESI L; MELDOLESI U
Pulmonary embolism diagnosis. What role for nuclear medicine.
2001 Pistolesi M;Pupi A
Technetium-99m sestamibi imaging to predict left ventricular ejection fraction outcome after revascularization in patients with chronic coronary artery disease and left ventricular dysfunction: comparison between baseline and nitrate-enhanced imaging.
2001 R. SCIAGRA'; LEONCINI L; MARCUCCI G; DABIZZI RP; PUPI A.
Synthesis and preliminary biological characterization of a new potential (125)I-radioligand for dopamine and serotonin receptors.
2001 GUARNA A; MENCHI G; BERTI G; CINI N; BOTTONCETTI A; RASPANTI S; POLITI A; A. PUPI
European Association of Nuclear Medicine procedure guidelines for brain imaging using [(18)F]FDG.
2002 BARTENSTEIN P; ASENBAUM S; CATAFAU A; HALLDIN C; PILOWSKI L; A. PUPI; TATSCH K; EUROPEAN ASSOCIATION OF NUCLEAR MEDICINE.
European Association of Nuclear Medicine procedure guidelines for brain perfusion SPET using (99m)Tc-labelled radiopharmaceuticals.
2002 TATSCH K; ASENBAUM S; BARTENSTEIN P; CATAFAU A; HALLDIN C; PILOWSKY LS; A. PUPI; EUROPEAN ASSOCIATION OF NUCLEAR MEDICINE.
European association of nuclear medicine procedure guidelines for brain neurotransmission SPET using I-123-labelled dopamine transporter ligands
2002 Tatsch K, Asenbaum S, Bartenstein P, Catafau A, Halldin C, Pilowsky LS, Pupi A; European Association of Nuclear Medicine.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile